NOVO NORDISK A S (NVO)
Clinical trial NCT07157423 updates: 1. completion date: 2027-03-26 → 2027-08-26 2. primary completion date: 2027-03-26 → 2027-08-26
Clinical trial NCT07157423 updates: 1. completion date: 2027-03-26 → 2027-08-26 2. primary completion date: 2027-03-26 → 2027-08-26
Clinical trial NCT07220954 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-04-01 → 2027-05-21 3. primary completion date: 2026-09-09 → 2026-09-17 4. enrollment: 21 → 19 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05176639: start date: 2021-12-03 → 2022-11-16.
Clinical trial NCT07000110: enrollment: 3195 → 3506 participants.
Clinical trial NCT03814746: enrollment: 255 → 254 participants.
Clinical trial NCT06677892 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 75 → 66 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05910658 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-10-18 → 2024-07-18
Clinical trial NCT07348640 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-02-02 → 2026-07-28
Clinical trial NCT03389802 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-30 → 2026-07-20
Clinical trial NCT06101342: primary completion date: 2028-01-01 → 2026-07-27.